Skip to main content
Clinical Trials/NCT05071040
NCT05071040
Recruiting
Not Applicable

Reduction of Sarcopenia Through a Home-based, App-monitored, Physical Exercise Intervention

Scientific Institute San Raffaele1 site in 1 country198 target enrollmentFebruary 1, 2022
ConditionsSarcopenia

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Sarcopenia
Sponsor
Scientific Institute San Raffaele
Enrollment
198
Locations
1
Primary Endpoint
Muscle strenght improvement
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

Sarcopenia is a pathophysiological process associated with aging and some metabolic conditions characterized by progressive muscle tissue loss, which may lead to loss of strength and performance and increased risk of falls and fractures, physical disability and premature death. With the present project the investigator aim to assess the effect of a feasible exercise program to improve muscle strength (primary outcome), and muscle volume and performance and other measures potentially associated with sarcopenia (secondary outcomes) in elderly and people living with HIV (PLWH) with sarcopenia. The investigators plan to enroll 98 elderly and 98 PLWH in a multicentric, 48-week, randomized, parallel-group, open label, superiority trial comparing the effect of a home-based and app-monitored strength exercise intervention versus no intervention. The investigators expect that participants who exercise will improve strength and other parameters and that improvement at week 12 and week 48 will be higher than in no-exercise controls.

Registry
clinicaltrials.gov
Start Date
February 1, 2022
End Date
October 15, 2024
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Scientific Institute San Raffaele
Responsible Party
Principal Investigator
Principal Investigator

Paola Cinque

Principal Investigator

Scientific Institute San Raffaele

Eligibility Criteria

Inclusion Criteria

  • Sedentary
  • \>60 year-old in the elderly group or \>50 year-old for the PLWH group;
  • with sarcopenia, as defined by both relative loss of muscle mass by bioimpedentiometry (BIA) and low muscle strength by handgrip

Exclusion Criteria

  • Any disease requiring hospitalization in the 6 weeks before enrollment;
  • Medical conditions contraindicating the proposed exercise as established by a sport medicine specialist;
  • Current substance or alcohol abuse or use of drugs that may influence balance and coordination;
  • Not being able to walk without assistance and to perform the prescribed exercises as by protocol.

Outcomes

Primary Outcomes

Muscle strenght improvement

Time Frame: Week 12

To assess the effect of exercise on muscle strength assess by the handgrip, in elderly people and PLWH, through comparison between an experimental and a control group.

Study Sites (1)

Loading locations...

Similar Trials